EasyManua.ls Logo

InterX 5002 - Page 9

InterX 5002
40 pages
Print Icon
To Next Page IconTo Next Page
To Next Page IconTo Next Page
To Previous Page IconTo Previous Page
To Previous Page IconTo Previous Page
Loading...
Warnings (cont.)
Stimulus delivered by this device may cause electrocution. Electrical current
of this magnitude must not flow through the thorax or carotid sinus nerves
because it may cause cardiac arrhythmia or interfere with cardiac function.
Use caution in applying the InterX 5002 over areas which are swollen,
infected, or inflamed as this may result in a worsening of symptoms. In
particular, caution should be taken when electrodes are placed over areas
associated with phlebitis, thrombophlebitis and varicose veins as these
conditions present an increased risk of forming blood clots which could
become dislodged during stimulation.
Use caution in applying the InterX 5002 to patients suspected of having
heart disease.
If the display becomes blank or inoperative discontinue use.
Do not make contact with the InterX 5002 electrodes on wet skin. Natural
bodily fluids, including sweat, are acceptable.
Extreme heat or cold may effect the operation of the InterX 5002.
Electronic monitoring equipment (such as ECG monitors and ECG alarms)
may not operate properly when stimulation is in use.
Do not use on patients that are undergoing dialysis or are being treated in an
MRI, X-ray, or with other diagnostic equipment that may be impacted by the
electrical impulses. Remove all jewelry before treatment.
The InterX 5002 is not to be used in the presence of anesthetic or other
flammable gases.
The InterX 5002 has no curative value.
Avoid placing the device on the skin when turning on or returning from
pause to avoid electrical signal.
Treatments with the InterX 5002 should not exceed 1 hour in any specific area
of the body and there should be a minimum of 2 hours between treatment
sessions, to avoid isolated cases of skin irritation.
Skin irritation, bruising, electrode burns, dizziness, nausea, and headaches
are potential adverse reactions.
5